Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Clinical end points in coronary stent trials: a case for standardized definitions.

Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW; Academic Research Consortium.

Circulation. 2007 May 1;115(17):2344-51.

2.

Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium.

Leon MB, Piazza N, Nikolsky E, Blackstone EH, Cutlip DE, Kappetein AP, Krucoff MW, Mack M, Mehran R, Miller C, Morel MA, Petersen J, Popma JJ, Takkenberg JJ, Vahanian A, van Es GA, Vranckx P, Webb JG, Windecker S, Serruys PW.

J Am Coll Cardiol. 2011 Jan 18;57(3):253-69. doi: 10.1016/j.jacc.2010.12.005. Epub 2011 Jan 7.

3.

The problem with composite end points in cardiovascular studies: the story of major adverse cardiac events and percutaneous coronary intervention.

Kip KE, Hollabaugh K, Marroquin OC, Williams DO.

J Am Coll Cardiol. 2008 Feb 19;51(7):701-7. doi: 10.1016/j.jacc.2007.10.034. Review.

4.

The effect of drug-eluting stents on intermediate angiographic and clinical outcomes in diabetic patients: insights from randomized clinical trials.

Kumbhani DJ, Bavry AA, Kamdar AR, Helton TJ, Bhatt DL.

Am Heart J. 2008 Apr;155(4):640-7. doi: 10.1016/j.ahj.2007.11.017. Epub 2008 Feb 21. Review.

PMID:
18371470
5.

Overview of the 2006 Food and Drug Administration Circulatory System Devices Panel meeting on drug-eluting stent thrombosis.

Pinto Slottow TL, Waksman R.

Catheter Cardiovasc Interv. 2007 Jun 1;69(7):1064-74.

PMID:
17525967
6.

Drug-eluting stent safety.

Slottow TL, Waksman R.

Am J Cardiol. 2007 Oct 22;100(8B):10M-17M. Review.

PMID:
17950827
7.

A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease.

Schömig A, Dibra A, Windecker S, Mehilli J, Suárez de Lezo J, Kaiser C, Park SJ, Goy JJ, Lee JH, Di Lorenzo E, Wu J, Jüni P, Pfisterer ME, Meier B, Kastrati A.

J Am Coll Cardiol. 2007 Oct 2;50(14):1373-80. Epub 2007 Aug 21. Review.

8.

A critical appraisal of the safety and efficacy of drug-eluting stents.

Maluenda G, Lemesle G, Waksman R.

Clin Pharmacol Ther. 2009 May;85(5):474-80. doi: 10.1038/clpt.2009.8. Epub 2009 Mar 11. Review.

PMID:
19279567
9.

[Stent thrombosis in the era of drug-eluting stents].

Wöhrle J.

Herz. 2007 Aug;32(5):411-8. Review. German.

PMID:
17687531
10.

Design criteria for the ideal drug-eluting stent.

Ako J, Bonneau HN, Honda Y, Fitzgerald PJ.

Am J Cardiol. 2007 Oct 22;100(8B):3M-9M. Review.

PMID:
17950830
11.

Antiplatelet therapy following drug-eluting stent implantation: new clinical data and recommendations.

Paradis JM, Ducrocq G, Tanguay JF.

Minerva Cardioangiol. 2008 Feb;56(1):139-54. Review.

PMID:
18432176
12.

Standardized reporting of bleeding complications for clinical investigations in acute coronary syndromes: a proposal from the academic bleeding consensus (ABC) multidisciplinary working group.

Rao SV, Eikelboom J, Steg PG, Lincoff AM, Weintraub WS, Bassand JP, Rao AK, Gibson CM, Petersen JL, Mehran R, Manoukian SV, Charnigo R, Lee KL, Moscucci M, Harrington RA; Academic Bleeding Consensus Multidisciplinary Working Group.

Am Heart J. 2009 Dec;158(6):881-886.e1. doi: 10.1016/j.ahj.2009.10.008.

PMID:
19958852
13.

Emergency percutaneous coronary intervention (PCI) for the care of patients with ST-elevation myocardial infarction (STEMI).

Morrison DA, Berman M, El-Amin O, McLaughlin RT, Bates ER.

Minerva Cardioangiol. 2007 Oct;55(5):593-623. Review.

PMID:
17912165
14.

Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction.

Kastrati A, Dibra A, Spaulding C, Laarman GJ, Menichelli M, Valgimigli M, Di Lorenzo E, Kaiser C, Tierala I, Mehilli J, Seyfarth M, Varenne O, Dirksen MT, Percoco G, Varricchio A, Pittl U, Syvänne M, Suttorp MJ, Violini R, Schömig A.

Eur Heart J. 2007 Nov;28(22):2706-13. Epub 2007 Sep 27. Review.

PMID:
17901079
15.

Understanding the drug-eluting stent trials.

Coolong A, Kuntz RE.

Am J Cardiol. 2007 Sep 3;100(5A):17K-24K. Epub 2007 Jun 26. Review.

PMID:
17719349
16.

[Drug-eluting stents for diabetic patients. A critical appraisal of the currently available data from randomized trials].

Silber S, Herdeg C.

Herz. 2008 Apr;33(3):196-205. doi: 10.1007/s00059-008-3121-5. Review. German.

PMID:
18568314
17.
18.

Balancing efficacy and safety of drug-eluting stents in patients undergoing percutaneous coronary intervention.

Jeremias A, Kirtane A.

Ann Intern Med. 2008 Feb 5;148(3):234-8. Epub 2007 Dec 17. Review.

PMID:
18087049
19.

Thrombosis and drug-eluting stents: an objective appraisal.

Holmes DR Jr, Kereiakes DJ, Laskey WK, Colombo A, Ellis SG, Henry TD, Popma JJ, Serruys PW, Kimura T, Williams DO, Windecker S, Krucoff MW.

J Am Coll Cardiol. 2007 Jul 10;50(2):109-18. Epub 2007 May 22. Review.

20.

Standardized definitions and clinical endpoints in trials investigating endovascular repair of aortic dissections.

Diehm N, Vermassen F, van Sambeek MR; DEFINE Investigators.

Eur J Vasc Endovasc Surg. 2013 Dec;46(6):645-50. doi: 10.1016/j.ejvs.2013.08.017. Epub 2013 Sep 6.

Supplemental Content

Support Center